医学
致盲
甲状腺
食品药品监督管理局
发病机制
甲状腺疾病
眼病
疾病
眼科
皮肤病科
内科学
药理学
临床试验
作者
Raymond S. Douglas,George J. Kahaly,Ami Patel,Saba Sile,Elizabeth H. Thompson,Renee Perdok,James C. Fleming,Brian Fowler,Claudio Marcocci,Michele Marinò,Alessandro Antonelli,Roger A. Dailey,Gerald J. Harris,Anja Eckstein,Jade S. Schiffman,Rosa A. Tang,Christine C. Nelson,Mario Salvi,Sara T. Wester,Jeffrey W. Sherman,Thomas Vescio,Robert J. Holt,Terry J. Smith
标识
DOI：10.1056/nejmoa1910434
摘要
Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition for which no Food and Drug Administration–approved medical therapy is available. Strong evidence has implicated the insulin-like growth factor I receptor (IGF-IR) in the pathogenesis of this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cctv18
shinysparrow
个性的紫菜
gjww
wk990240
寻道图强
敬老院1号
酸化土壤改良
iVANPENNY
不安青牛
寻寻觅觅呢
凤凰
benben
罗_
柯一一
SCINEXUS
Maimai
紫金大萝卜
SOLOMON
pluto
皖公网安备34019202002308
